The trajectory of Sildenafil presents a intricate picture for those considering investment. While the initial introduction generated substantial returns, the expiration of its exclusive rights opened the floodgates to off-brand versions, dramatically eroding revenue. This creates a unique risk for firms relying on related blockbuster products, sugg

The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in revenue , its intellectual property lapse created a flood of knock-off medications, significantly eroding its position . While specific firms may attempt to capitalize on similar conditions , the curre